Alice Pedrali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alice Pedrali has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Daniela Rossi
Department of Drug Sciences, Medicinal Chemistry and Pharmaceutical Technology Section, University of Pavia, Pavia, Italy
4 shared publications- Dirk Schepmann
Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, D-48149 Münster, Germany
4 shared publications - Giorgio Marrubini
Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy
4 shared publications - Simona Collina
Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy
4 shared publications Daniela Curti
Department of Biology and Biotechnology “L. Spallanzani”, Laboratory of Cellular and Molecular Neuropharmacology University of Pavia Pavia Italy
3 shared publicationsGabriella Massolini
Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy
3 shared publications
Latest Publications
- 1 September 2020
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 123, 345-353
Lipase-mediated hydrolysis of hempseed oil in a packed-bed reactor and in-line purification of PUFA as mono- and diacylglycerols
- 1 September 2020
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 123, 345-353
Lipase-mediated hydrolysis of hempseed oil in a packed-bed reactor and in-line purification of PUFA as mono- and diacylglycerols
- 24 July 2014
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 116 (11) , 1496-1504
Preparation of PUFA concentrates as acylglycerols via enzymatic hydrolysis of hempseed oil (Cannabis sativa L.) in a homogeneous low‐water medium
The growing demand for concentrated extracts of PUFA prompted us to undertake the preparation of natural glycerides containing linoleic acid and α‐linolenic acid from hempseed oil. Hempseed is an exceptionally rich source of essential FA but is still underutilized. Hempseed oil was thus submitted to a lipase‐catalyzed hydrolysis in a homogeneous medium based on oil and t‐BuOH/water. Seven commercial lipases were screened in this reaction medium, which resulted to be superior to the routinely used biphasic systems in terms of substrate/product solubility and biocatalyst stability. Lipase from Pseudomonas cepacia resulted to be sufficiently selective versus saturated FA and it was thus used to hydrolyze hempseed oil in order to obtain acylglycerols enriched with PUFA. The enzymatic reaction was scaled up and the acylglycerol components were purified and analyzed by GC‐FID. In the fraction of monoacylglycerols (yield 22%) the total amount of PUFA reached 85% (against 77% of the crude oil) whereas the content of saturated FA was negligible. The omega‐6/omega‐3 ratio of the total glyceride component (purified acylglycerols, yield 29%) was maintained in the optimal range (4.6:1) for human nutrition. Therefore, PUFA concentrates from hempseed oil here obtained in the form of natural glycerides could be considered as valuable dietary supplements.Practical applications: The enzymatic method here described allows to directly achieve pure monoglycerides of PUFA with a potential nutraceutical use. This procedure has the advantage to occur under very mild conditions in a homogeneous medium composed of a water miscible green solvent, to be easily scalable and to rely on a standard chromatography purification step.PUFA‐based glyceride concentrates from hempseed oil have been prepared by a fully enzymatic process in a new, homogeneous, green medium. In monoacylglycerols, content of saturated FA was significantly reduced and the omega‐6/omega‐3 ratio was maintained in the optimal range for nutritional needs.
- 24 July 2014
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 116 (11) , 1496-1504
Preparation of PUFA concentrates as acylglycerols via enzymatic hydrolysis of hempseed oil (Cannabis sativa L.) in a homogeneous low‐water medium
The growing demand for concentrated extracts of PUFA prompted us to undertake the preparation of natural glycerides containing linoleic acid and α‐linolenic acid from hempseed oil. Hempseed is an exceptionally rich source of essential FA but is still underutilized. Hempseed oil was thus submitted to a lipase‐catalyzed hydrolysis in a homogeneous medium based on oil and t‐BuOH/water. Seven commercial lipases were screened in this reaction medium, which resulted to be superior to the routinely used biphasic systems in terms of substrate/product solubility and biocatalyst stability. Lipase from Pseudomonas cepacia resulted to be sufficiently selective versus saturated FA and it was thus used to hydrolyze hempseed oil in order to obtain acylglycerols enriched with PUFA. The enzymatic reaction was scaled up and the acylglycerol components were purified and analyzed by GC‐FID. In the fraction of monoacylglycerols (yield 22%) the total amount of PUFA reached 85% (against 77% of the crude oil) whereas the content of saturated FA was negligible. The omega‐6/omega‐3 ratio of the total glyceride component (purified acylglycerols, yield 29%) was maintained in the optimal range (4.6:1) for human nutrition. Therefore, PUFA concentrates from hempseed oil here obtained in the form of natural glycerides could be considered as valuable dietary supplements.Practical applications: The enzymatic method here described allows to directly achieve pure monoglycerides of PUFA with a potential nutraceutical use. This procedure has the advantage to occur under very mild conditions in a homogeneous medium composed of a water miscible green solvent, to be easily scalable and to rely on a standard chromatography purification step.PUFA‐based glyceride concentrates from hempseed oil have been prepared by a fully enzymatic process in a new, homogeneous, green medium. In monoacylglycerols, content of saturated FA was significantly reduced and the omega‐6/omega‐3 ratio was maintained in the optimal range for nutritional needs.
- Open Access
Characterization of Intact Neo-Glycoproteins by Hydrophilic Interaction Liquid Chromatography
In this study, an HPLC HILIC-UV method was developed for the analysis of intact neo-glycoproteins. During method development the experimental conditions evaluated involved different HILIC columns (TSKgel Amide-80 and ZIC-pHILIC), and water-acetonitrile mixtures containing various types of acids and salts. The final selected method was based on a TSKgel Amide-80 column and a mobile phase composed of acetonitrile and water both containing 10 mM HClO4. The influence of temperature and sample preparation on the chromatographic performances of the HILIC method was also investigated. The method was applied to the separation of neo-glycoproteins prepared starting from the model protein RNase A by chemical conjugation of different glycans. Using the method here reported it was possible to monitor by UV detection the glycosylation reaction and assess the distribution of neo-glycoprotein isoforms without laborious sample workup prior to analysis.
Open AccessCharacterization of Intact Neo-Glycoproteins by Hydrophilic Interaction Liquid Chromatography
In this study, an HPLC HILIC-UV method was developed for the analysis of intact neo-glycoproteins. During method development the experimental conditions evaluated involved different HILIC columns (TSKgel Amide-80 and ZIC-pHILIC), and water-acetonitrile mixtures containing various types of acids and salts. The final selected method was based on a TSKgel Amide-80 column and a mobile phase composed of acetonitrile and water both containing 10 mM HClO4. The influence of temperature and sample preparation on the chromatographic performances of the HILIC method was also investigated. The method was applied to the separation of neo-glycoproteins prepared starting from the model protein RNase A by chemical conjugation of different glycans. Using the method here reported it was possible to monitor by UV detection the glycosylation reaction and assess the distribution of neo-glycoprotein isoforms without laborious sample workup prior to analysis.
- 1 October 2013
- Published by Wiley in Journal of Separation Science
- Vol. 36 (21-22) , 3493-3502
Column comparison and method development for the analysis of short‐chain carboxylic acids by zwitterionic hydrophilic interaction liquid chromatography with UV detection
Short‐chain carboxylic acids are relevant in pharmaceutical, food quality control, and biomedical analysis. In this study, 11 acids commonly found in drugs and in food products were selected. Wine was chosen as matrix for testing the method. The test compounds were used for comparing the selectivity of four 150 × 2.1 mm zwitterionic hydrophilic interaction LC (HILIC) columns (ZIC‐HILIC 5 μm, 200 Å, and 3.5 μm, 100 Å, ZIC‐pHILIC 5 μm, ZIC‐cHILIC 3 μm, 100 Å) while varying the conditions to optimize for low UV wavelength detection and achieve high sensitivity. Retention using potassium phosphate and ammonium carbonate as mobile‐phase components at pH 6.0, 7.5, and 8.5–8.9 was studied considering recent hypotheses on HILIC mechanism‐related with the Hofmeister series effect and ion hydration. An isocratic method with UV detection at 200 nm and mobile phase consisting of 75% acetonitrile and 10 mM potassium phosphate at pH 6.0 applied to a ZIC‐cHILIC column was found provisionally optimal and partially validated for the 11 analytes. Satisfactory results (R2 from 0.9940 to >0.9999), and recoveries from 93–106% for all analytes evidenced the method as suitable for wine analysis. To the best of our knowledge, no previous study has reported on the direct ZIC‐HILIC separation and UV detection of the acids considered here in wine.
- 1 October 2013
- Published by Wiley in Journal of Separation Science
- Vol. 36 (21-22) , 3493-3502
Column comparison and method development for the analysis of short‐chain carboxylic acids by zwitterionic hydrophilic interaction liquid chromatography with UV detection
Short‐chain carboxylic acids are relevant in pharmaceutical, food quality control, and biomedical analysis. In this study, 11 acids commonly found in drugs and in food products were selected. Wine was chosen as matrix for testing the method. The test compounds were used for comparing the selectivity of four 150 × 2.1 mm zwitterionic hydrophilic interaction LC (HILIC) columns (ZIC‐HILIC 5 μm, 200 Å, and 3.5 μm, 100 Å, ZIC‐pHILIC 5 μm, ZIC‐cHILIC 3 μm, 100 Å) while varying the conditions to optimize for low UV wavelength detection and achieve high sensitivity. Retention using potassium phosphate and ammonium carbonate as mobile‐phase components at pH 6.0, 7.5, and 8.5–8.9 was studied considering recent hypotheses on HILIC mechanism‐related with the Hofmeister series effect and ion hydration. An isocratic method with UV detection at 200 nm and mobile phase consisting of 75% acetonitrile and 10 mM potassium phosphate at pH 6.0 applied to a ZIC‐cHILIC column was found provisionally optimal and partially validated for the 11 analytes. Satisfactory results (R2 from 0.9940 to >0.9999), and recoveries from 93–106% for all analytes evidenced the method as suitable for wine analysis. To the best of our knowledge, no previous study has reported on the direct ZIC‐HILIC separation and UV detection of the acids considered here in wine.
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile
In this study we addressed the role of chirality in the biological activity of RC-33, recently studied by us in its racemic form. An asymmetric synthesis procedure was the first experiment, leading to the desired enantioenriched RC-33 but with an enantiomeric excess (ee) not good enough for supporting the in vitro investigation. An enantioselective high-performance liquid chromatography (HPLC) procedure was then successfully carried out, yielding both RC-33 enantiomers in amounts and optical purity suitable for the pharmacological study. The absolute configuration of pure enantiomers was easily assigned exploiting the asymmetric synthesis previously devised. As emerged in the preliminary in vitro biological investigation, (S)- and (R)-RC-33 possess a comparable affinity towards the σ1 receptor and a very a similar behavior in the calcium influx assay, resulting in an equally effective σ1 receptor agonist. Overall, the results obtained so far suggest that the interaction with the biological target is nonstereoselective and leads us to hypothesize that there is a lack of stereoselectivity in the biological activity of RC-33. Chirality 25:814–822, 2013.
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile
In this study we addressed the role of chirality in the biological activity of RC-33, recently studied by us in its racemic form. An asymmetric synthesis procedure was the first experiment, leading to the desired enantioenriched RC-33 but with an enantiomeric excess (ee) not good enough for supporting the in vitro investigation. An enantioselective high-performance liquid chromatography (HPLC) procedure was then successfully carried out, yielding both RC-33 enantiomers in amounts and optical purity suitable for the pharmacological study. The absolute configuration of pure enantiomers was easily assigned exploiting the asymmetric synthesis previously devised. As emerged in the preliminary in vitro biological investigation, (S)- and (R)-RC-33 possess a comparable affinity towards the σ1 receptor and a very a similar behavior in the calcium influx assay, resulting in an equally effective σ1 receptor agonist. Overall, the results obtained so far suggest that the interaction with the biological target is nonstereoselective and leads us to hypothesize that there is a lack of stereoselectivity in the biological activity of RC-33. Chirality 25:814–822, 2013.
- 5 July 2013
- Published by Wiley in ChemMedChem
- Vol. 8 (9) , 1514-1527
Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective Agents Acting as σ1 Receptor Agonists
Our recent research efforts identified racemic RC‐33 as a potent and metabolically stable σ1 receptor agonist. Herein we describe the isolation of pure RC‐33 enantiomers by chiral chromatography, assignment of their absolute configuration, and in vitro biological studies in order to address the role of chirality in the biological activity of these compounds and their metabolic processing. The binding of enantiopure RC‐33 to the σ1 receptor was also investigated in silico by molecular dynamics simulations. Both RC‐33 enantiomers showed similar affinities for the σ1 receptor and appeared to be almost equally effective as σ1 receptor agonists. However, the R‐configured enantiomer showed higher in vitro hepatic metabolic stability in the presence of NADPH than the S enantiomer. Overall, the results presented herein led us to select (R)‐RC‐33 as the optimal candidate for further in vivo studies in an animal model of amyotrophic lateral sclerosis.
- 5 July 2013
- Published by Wiley in ChemMedChem
- Vol. 8 (9) , 1514-1527
Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective Agents Acting as σ1 Receptor Agonists
Our recent research efforts identified racemic RC‐33 as a potent and metabolically stable σ1 receptor agonist. Herein we describe the isolation of pure RC‐33 enantiomers by chiral chromatography, assignment of their absolute configuration, and in vitro biological studies in order to address the role of chirality in the biological activity of these compounds and their metabolic processing. The binding of enantiopure RC‐33 to the σ1 receptor was also investigated in silico by molecular dynamics simulations. Both RC‐33 enantiomers showed similar affinities for the σ1 receptor and appeared to be almost equally effective as σ1 receptor agonists. However, the R‐configured enantiomer showed higher in vitro hepatic metabolic stability in the presence of NADPH than the S enantiomer. Overall, the results presented herein led us to select (R)‐RC‐33 as the optimal candidate for further in vivo studies in an animal model of amyotrophic lateral sclerosis.
- 1 November 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (21) , 6210-6224
Identification of a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells
- 1 November 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (21) , 6210-6224
Identification of a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells
- 1 February 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (3) , 1204-1212
Design, synthesis and SAR analysis of novel selective σ1 ligands (Part 2)
- 1 February 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (3) , 1204-1212
Design, synthesis and SAR analysis of novel selective σ1 ligands (Part 2)